Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Trading Statement

14 Mar 2018 07:00

RNS Number : 6253H
Alumasc Group PLC
14 March 2018
 

IMMEDIATE RELEASE 14 March 2018

 

The Alumasc Group plc (ALU.L) ("Alumasc" or the "group")

 

Trading Statement

 

Alumasc has so far experienced a slower than expected third quarter performance, both in terms of revenue and order intake. The principal reasons are macro-economic and industry specific:

· continuing delays in building contractor customers committing to new work following recent margin pressures, exacerbated in January by the insolvency of Carillion and the consequential impact across the industry;

· broader economic and political uncertainties impacting demand particularly in the commercial new build sector, with recent reports of construction output in this sector showing decline;

· delays to public housing refurbishment contracts in Scotland; and

· severe winter weather over the last few weeks.

These issues have had an impact particularly on Levolux's UK Solar Shading business, the Roofing & Walling division and the Gatic business within the Water Management division. It is likely that the first three of these factors will also impact the group's final quarter performance.

In contrast, areas where Alumasc's products and systems are sold via building distribution channels continue to perform well, with revenue growth remaining ahead of UK construction market growth at Alumasc Water Management Solutions, Rainclear and Timloc.

In view of all the above, the Board's latest forecasts are that group revenues for the year ending 30 June 2018 will be 4-5% below previous expectations, with a consequential reduction in previously expected underlying profit before tax of around 15%.

The integration of Wade, the specialist drainage business acquired by Alumasc on 1 February 2018, is progressing well and the Board believes that potential synergies as part of Alumasc's broader Water Management division and its "rain to drain" strategy are significant.

Whilst Alumasc is not immune to current market headwinds, there have been numerous positive strategic developments across the group over the last year that make Alumasc well positioned to continue its recent underlying growth trajectory over the medium to longer term. The level of specifications and the value of pre-order pipelines remain strong across the group, particularly Levolux's relatively new business streams of North American Solar Shading & Screening and UK Balconies & Balustrading where market share is growing rapidly from a low base. 

The Board continues to have confidence in the future growth prospects of the group in view of:

· The strategic positioning of our businesses in specialist growth markets;

· The consistent investment in recent years in growth resources and additional capacity, including the successful commissioning of the new Timloc factory in January;

· Levolux and Alumasc Water Management's potential to further develop export markets; and

· The recent acquisition of Wade, a high-quality business with development and synergy potential.

 

Enquiries:

The Alumasc Group plc

Paul Hooper (Chief Executive) 01536 383821

Andrew Magson (Finance Director) 01536 383844

 

Glenmill Partners Limited

Simon Bloomfield 07771 758514

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFTVRIVLIT
Date   Source Headline
20th Sep 201911:29 amRNSNotice of AGM
20th Sep 20197:00 amRNSDirectorate Change
11th Sep 201912:10 pmRNSDirector/PDMR Shareholding
5th Sep 20197:00 amRNSDirectorate Changes
5th Sep 20197:00 amRNSFull Year Results
17th Jul 201910:52 amRNSNotice of Results
28th Jun 201911:00 amRNSUpdate on Levolux strategy
25th Jun 20197:00 amRNSAIM Admission
21st Jun 20198:00 amRNSSchedule One update - The Alumasc Group Limited
20th Jun 20195:30 pmRNSAlumasc Group
14th Jun 20197:00 amRNSTrading Update
3rd Jun 20199:24 amRNSTotal Voting Rights
23rd May 201911:55 amRNSResult of General Meeting
9th May 20193:53 pmRNSDirector/PDMR Shareholding
3rd May 20192:37 pmRNSDirector/PDMR Shareholding
30th Apr 20193:00 pmRNSSchedule One - The Alumasc Group plc
26th Apr 20197:00 amRNSPROPOSED ADMISSION TO TRADING ON AIM
23rd Apr 201910:13 amRNSDirector/PDMR Shareholding
23rd Apr 201910:13 amRNSDirector/PDMR Shareholding
28th Mar 20199:51 amRNSDirector/PDMR Shareholding
5th Feb 20193:03 pmRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSHalf-year Report
15th Jan 20197:00 amRNSBoard Changes
14th Jan 20191:30 pmRNSInterim Results Announcement Date
19th Dec 201810:30 amRNSChange of auditor
26th Nov 201811:14 amRNSDirector/PDMR Shareholding
8th Nov 201811:30 amRNSDirector/PDMR Shareholding
8th Nov 201811:26 amRNSDirector/PDMR Shareholding
2nd Nov 20187:00 amRNSAppointment of Non-Executive Director
1st Nov 20187:00 amRNSSale of Facades Business
25th Oct 20184:48 pmRNSResults of AGM
25th Oct 20187:00 amRNSAGM trading update
25th Oct 20187:00 amRNS2018 AGM Trading Statement
11th Sep 20187:00 amRNSFULL YEAR RESULTS ANNOUNCEMENT
21st Aug 20189:26 amRNSNotice of Results
2nd Jul 20182:39 pmRNSDirectorate Change
24th May 20182:54 pmRNSDirector/PDMR Shareholding
15th May 20187:00 amRNSTrading Statement
4th Apr 20181:55 pmRNSDirector/PDMR Shareholding
28th Mar 201812:12 pmRNSHolding(s) in Company
22nd Mar 20184:50 pmRNSDirector/PDMR Shareholding
22nd Mar 20189:16 amRNSDirector/PDMR Shareholding
22nd Mar 20189:15 amRNSDirector/PDMR Shareholding
20th Mar 20182:05 pmRNSDirector/PDMR Shareholding
14th Mar 20187:00 amRNSTrading Statement
23rd Feb 20189:30 amRNSHolding(s) in Company
15th Feb 201810:31 amRNSDirector/PDMR Shareholding
15th Feb 201810:30 amRNSDirector/PDMR Shareholding
12th Feb 20183:00 pmRNSDirector/PDMR Shareholding
12th Feb 20183:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.